BaseFortify

Publication date: 2026-01-20

Last updated on: 2026-01-29

Assigner: Oracle

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).

CVSS Scores

EPSS Scores

Probability:
Percentile:

Meta Information

Published

2026-01-20

Last Modified

2026-01-29

Generated

2026-07-06

AI Q&A

2026-01-21

EPSS Evaluated

2026-07-05

NVD

CVE-2026-21970

EUVD

EUVD-2026-3542

Affected Vendors & Products

Vendor	Product	Version / Range
oracle	life_sciences_central_designer	7.0.1.0

Helpful Resources

Exploitability

CWE

KEV

CWE ID	Description
CWE-NVD-CWE-noinfo

Attack-Flow Graph

Executive Summary

This vulnerability exists in Oracle Life Sciences Central Designer version 7.0.1.0. It allows a low privileged attacker with network access via HTTP to exploit the system easily. Successful exploitation can lead to unauthorized access to critical or all accessible data within Oracle Life Sciences Central Designer.

Impact Analysis

The impact of this vulnerability is unauthorized access to critical data or complete access to all data accessible through Oracle Life Sciences Central Designer. This could compromise confidentiality of sensitive information.

Hi! I’m here to help you understand CVE-2026-21970. Ask me anything about the vulnerability, its impact, or mitigation strategies.

0/70